Bausch Health Companies Inc.
A Canadian healthcare company behind some of the world's best-known eye and skin products, Bausch Health makes contact lenses, dry-eye treatments, and the Thermage skin-tightening device, while its Salix arm sells the gut medicine Xifaxan. Its roots trace to an 1853 Rochester optical shop founded by John Jacob Bausch, who borrowed money from friend Henry Lomb to get the business going. The company began as ICN Pharmaceuticals in 1959 and later renamed itself after the famous lens maker it acquired — the firm that brought America its first mass-produced soft contact lenses in 1971.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| NOMURA HOLDINGS INC | 13G/APassive | 4.2% | 15.71M | Nov 14, 2025 |
| NOMURA GLOBAL FINANCIAL PRODUCTS INC | 13G/APassive | 4.2% | 15.71M | Nov 14, 2025 |
| Icahn Partners Master Fund LP | 13D/AActivist | 0% | 0 | Aug 15, 2025 |
| Icahn Offshore LP | 13D/AActivist | 0% | 0 | Aug 15, 2025 |
| Icahn Partners LP | 13D/AActivist | 0% | 0 | Aug 15, 2025 |
| Icahn Onshore LP | 13D/AActivist | 0% | 0 | Aug 15, 2025 |
| Icahn Capital LP | 13D/AActivist | 0% | 0 | Aug 15, 2025 |
| IPH GP LLC | 13D/AActivist | 0% | 0 | Aug 15, 2025 |
| Icahn Enterprises Holdings L.P. | 13D/AActivist | 0% | 0 | Aug 15, 2025 |
| Icahn Enterprises G.P. Inc. | 13D/AActivist | 0% | 0 | Aug 15, 2025 |